88 results
8-K
EX-99.1
MRK
Merck & Co Inc
25 Apr 24
Merck Announces First-Quarter 2024 Financial Results
6:41am
Event
Merck will host an Oncology Investor Event to coincide with the American Society for Clinical Oncology Annual Meeting on Monday, June 3, 2024, 6
PX14A6G
Bowyer Research, Inc.
27 Mar 24
Letter to shareholders
8:57pm
Accommodation, The Federalist Society (Oct. 5, 2023), https://fedsoc.org/fedsoc-review/groff-v-dejoy-the-death-of-the-de-minimis-test-breathes-life
8-K
EX-99.1
MRK
Merck & Co Inc
26 Oct 23
Merck Announces Third-Quarter 2023 Financial Results
6:38am
RCC, and for KEYTRUDA in cervical cancer. Notably, Merck presented compelling new data at the European Society for Medical Oncology (ESMO) Congress 2023
8-K
EX-99.1
3yzjol6j68dn 5h
1 Aug 23
Merck Announces Second-Quarter 2023 Financial Results
6:46am
8-K
EX-99.1
h92yjyq7mvap
27 Apr 23
Merck Announces First-Quarter 2023 Financial Results
6:43am
PX14A6G
mvdz7n7j
12 Apr 23
Letter to shareholders
8:58am
8-K
EX-99.3
onrh1wnl0ui duyo1
27 Oct 22
Merck Announces Third-Quarter 2022 Financial Results
6:38am
8-K
EX-99.1
cpvomu212oho
27 Oct 22
Merck Announces Third-Quarter 2022 Financial Results
6:38am
8-K
EX-99.1
m9mevduw7260t
28 Jul 22
Merck Announces Second-Quarter 2022 Financial Results
6:36am
8-K
EX-99.1
m3bkl x3o24069i
28 Apr 22
Merck Announces First-Quarter 2022 Financial Results
6:35am
8-K
EX-99.1
ouji507z1nm2zblvlyd
3 Feb 22
Merck Announces Fourth-Quarter and Full-Year 2021 Financial Results
6:39am
8-K
EX-99.1
2c87iaza
28 Oct 21
Merck Announces Third-Quarter 2021 Financial Results
6:40am
8-K
EX-99.1
ndy8g9k fpdcuf97rno2
29 Jul 21
Merck Announces Second-Quarter 2021 Financial Results
7:01am